SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurobiological Tech (NTII)
NTII 0.00010000.0%Mar 7 3:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (563)5/21/1999 6:03:00 PM
From: BRAVEHEART  Read Replies (1) of 1494
 
On Green Eggs & SPAM,

John I attribute the two days heavy volume to NeuroInvestments Newsletter. Lots of 500 to 5,000 share buys. It is good to see NTI get some attention.

As far as A Pharma collaboration. Well it is dissapointing to hear that MERZ turned down an offer. That could mean a longer negotiation period.

I have heard that NTI does have potential investors lined up should such a delay occur. I would place the probability of a Pharma deal at say 50% pre end of June if what you say about MERZ rejecting a deal is true. I would also venture a guess that NTI is 99% likely to be able to raise additional funding should such a scenario play out.

Either way NTI is still undervalued in my opinion.

Jeffrey
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext